|
Clinical outcomes used as indicators to assess the performance of surgical services |
|
| Condition or Intervention |
Outcome measure |
|
|
|
| Bladder exstrophy |
Immediate complications |
| Bone cancer |
Three-year local recurrence |
| Adult Ventricular Assist Devices (Bridge to heart transplant) |
Survival |
| Child Ventricular Assist Devices/Extracorporeal Membrane Oxygenation (ECMO) (Bridge to heart transplant) |
Deaths |
| Complex tracheal disease |
Deaths, Re-intervention, Stents, Repeated outpatient attendances, Repeated inpatient attendances. |
| Craniofacial surgery |
Appropriate measure not clear |
| Extracorporeal Membrane Oxygenation (ECMO) (adult) |
Survival without severe disability at 6 months |
| Extracorporeal Membrane Oxygenation (ECMO) (neonate & infants, children) |
Survival to discharge |
| Malformation of female genital tract |
Research study published: 20-year outcome on sexual function [22]. |
| Ocular oncology |
Loss of eye (primary and secondary enucleation); Local recurrence. |
| Oculo-odonto-kerato-prosthesis |
Visual acuity |
| Pseudomyxoma of peritoneum |
Complications, median survival |
| Pulmonary thromboendarterectomy |
In-hospital mortality |
| Retinoblastoma |
Deaths; Loss of eye (primary and secondary enucleation); Metastasis. |
| Severe Combined Immunodeficiency |
Deaths |
| Transplant – heart |
Mortality at 30 days after transplant; Survival one and five years after transplant |
| Transplant – liver |
Mortality at 90 days after transplant; Survival five years after transplant |
| Transplant – lung |
Mortality at 90 days after transplant; Survival one and five years after transplant |
| Transplant – pancreas |
Mortality at 90 days after transplant; Survival five years after transplant |
| Transplant – small bowel |
Mortality at 90 days after transplant; Survival five years after transplant |
| Vein of Galen malformation |
Deaths and disability |
Kenny et al. Orphanet Journal of Rare Diseases 2008 3:23 doi:10.1186/1750-1172-3-23 |
|